About CBR – Cord Blood Registry

Founded in 1992, CBR is entrusted by parents with storing more than 900,000 cord blood and cord tissue samples for their children. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today.

CBR has helped more than 600 families use their cord blood stem cells for established and experimental medical treatments, more than any other family cord blood bank. CBRs goal is to expand the potential scope of newborn stem cell therapies that may be available to patients and their families.

CBR Cord Blood Registry is headquartered in Los Angeles, California. CBRs owned 80,000 square foot laboratory is located in Tucson, Arizona.

Cord Blood Registry is a registered trademark of CBR Systems, Inc.

CBR maintains standards for cellular therapy services through AABB accreditation, FDA-registration, and CLIA certification.

CBR has the longest history of accreditation with the AABB and the companys quality standards have been recognized through ISO 9001:2015 certification the global business standard for quality.

A pioneer in newborn stem cell collection and cryopreservation, CBR believes in the power of newborn stem cells to improve lives today and their potential to revolutionize treatment for many conditions in the future.

CBR is the first family newborn stem cell bank to partner with leading research institutions to establish FDA-regulated clinical trials exploring the potential regenerative ability of stem cells to help treat conditions that have no cure today, including: acquired hearing loss, autism, cerebral palsy, and pediatric stroke. In fact, 73% of the stem cell units released by CBR have been used for experimental regenerative therapies more than any other family cord blood bank in the world.

CBR created the worlds only collection device designed specifically for cord blood stem cells. CBRs Collection Kit contains everything the healthcare provider needs to help maximize the cord blood collection volume.

CBR developed a crush-resistant, temperature protected, and electronically tracked kit that actively transforms into a cube to encase the blood and/or tissue collection, helping to ensure that it is protected and delivered safely. On average, the transport time from the hospital to CBRs lab is 19 hours. CBR processes cord blood using the AutoXpress Platform* (AXP) a fully automated, functionally closed stem cell processing technology. CBR has the industrys highest published average cell recovery rate of 99%.1-3,8

*AXP and AutoXpress are registered trademarks of ThermoGenesis Corp

Excerpt from:

About CBR - Cord Blood Registry